Project Title: Novel strategies for pancreatic cancer treatment:
an epigenetic approach
Project Aims: Dr Froeling‘s project will focus on ‘epigenetics’ – changes in DNA that can switch genes on and off and lead to cancer without altering the genetic code itself. Dr Froeling and her team will profile different pancreatic tumours and cell lines to look for biomarkers that will enable them to predict which patients will respond best to the different drugs being developed to combat different epigenetic changes. This will allow individual patients to be matched with the most effective treatment for their type of tumour.